Artificial Intelligence (AI) is widely regarded as a technology which will impact the future competitiveness of the Germaneconomy. Looking at the research productivity of German scientists and universities in AI, we find that Germany definitively belongs tothe top performers in AI research...

In this paper we examine strategies of business incubation in the following countries: the USA, Germany and Russia using both a comparative theoretical analysis of different performance criteria of business incubators and interviewing experts who work directly with startup companies. We find...

Since the mid-1990s German technology policy has experienced a paradigmatic shift from standard grant schemes towards a region-oriented and competition-based R&D policy. Currently, a new policy experiment, the InterClust contest, is under way, trying to simultaneously foster place-based...

Based on a standard idea-based model of endogenous growth we test the hypothesis that regional innovative activity is path-dependent, and investigate the geographical scope of knowledge spillovers. Using data for West-German regions, two alternative indicators of the stock of knowledge are...

This paper studies the effect of R&D spillovers on R&D spending and productivity in a sample of German manufacturing firms. Using panel estimation techniques, the results suggest that spillovers affect industries in a heterogeneous manner. In terms of R&D investment, firms in high-technology...

As well as companies, private individuals are now increasingly making use of augmented reality. All too often, augmented reality is used as a synonym for smartglasses in the media. But it offers far more: supporting people in their day-to-day activities, extending their perception and...

The dynamics of drug launch has been an under-researched area. Most of the studies in this field focus on developed countries, quite uniform in terms of disease profile and regulatory framework, and analyse whether stringency in regulation influences launch delay. Developing countries, in...

The dynamics of drug launch has been an under-researched area. Most of the studies in this field focus on developed countries, quite uniform in terms of disease profile and regulatory framework, and analyse whether stringency in regulation influences launch delay. Developing countries, in...

The dynamics of drug launch has been an under-researched area. Most of the studies in this field focus on developed countries, quite uniform in terms of disease profile and regulatory framework, and analyse whether stringency in regulation influences launch delay. Developing countries, in...